Treace Medical Concepts (TMCI) Preferred Dividend Payments (2020 - 2021)

Treace Medical Concepts (TMCI) reported Preferred Dividend Payments of $39000.0 for Q2 2021, down 75.47% on a YoY basis from $159000.0 in Q2 2020, and down 75.32% quarter-over-quarter from $158000.0 in Q1 2021.

Treace Medical Concepts (TMCI) Preferred Dividend Payments (2020 - 2021) Analysis & Trends

Treace Medical Concepts has reported Preferred Dividend Payments for 2 years, with the latest figure at $39000.0 in Q2 2021.

  • For the quarter ending Q2 2021, Preferred Dividend Payments fell 75.47% year-over-year to $39000.0; the trailing twelve-month figure through Jun 2022 stood at $39000.0 (down 92.49% YoY), and the FY2021 full-year result was $196000.0, down 69.38% from the prior year.
  • Preferred Dividend Payments for Q2 2021 stood at $39000.0, down from $158000.0 in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $161000.0 in Q3 2020, with the low at $39000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Treace Medical Concepts 274.20 Mn 222.34 Mn 37.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 39,000.00
Mar 31, 2021 158,000.00
Dec 31, 2020 161,000.00
Sep 30, 2020 161,000.00
Jun 30, 2020 159,000.00
Mar 31, 2020 158,000.00